|
On apr 23, 2024, the following information was reported by the clinic to sciton clinical specialist: patient information: age: 50.Nationality: japanese.Skin type: iv.Initial visit (no prior cosmetic procedures).Medical history: past medical history: none.Present illness: none.Treatment was performed on (b)(6) 2024: it was reported that bbl treatment was administered by the physician for rejuvenation purposes, targeting liver spots.590nm, 10j, 20msec, 15°c, 15×45 - full face (large area), 1 pass, 50 shots 640nm, 10j, 20msec, 15°c, 15×45 - liver spots (cheeks, cheekbones), 1 pass, 20 shots 590nm, 12j, 20msec, 15°c, 15×15 - full face (small area), 1 pass, 50 shots treatment was started from the right side, with slight heat was felt on the left side.No complaints of pain or heat sensation during the procedure.Patient reported experiencing tingling sensation on the entire face on the way home.Follow-up treatments were performed on: ·(b)(6) 2024.Patient reported blister formation (timing unspecified).Patient visited a nearby dermatology clinic on (b)(6) 2024.Details of treatment are unclear.·(b)(6) 2024.Patient reported a linear 3cm blister residue on the left cheekbone, with mild pain.Prescribed azunol ointment (non-steroidal anti-inflammatory), provided adhesive bandage.·(b)(6) 2024.Blisters disappeared, leaving linear post-inflammatory hyperpigmentation (pih).Administered iontophoresis (vitamin c) treatment.Prescribed synalar, l-cysteine, and tranexamic acid.·(b)(6) 2024.Pih remained.Administered iontophoresis (vitamin c) treatment.Prescribed synalar, l-cysteine, and tranexamic acid.·(b)(6) 2024 pih persisted.Administered iontophoresis (vitamin c) treatment.Prescribed synalar, l-cysteine, and tranexamic acid.Patient has been visiting the clinic weekly and continuing with previous treatments.Additionally, hydroquinone ointment and bi-weekly chemical peel treatment has been added.
|